(1S,2R)-2-甲氧基环己烷胺 | 141553-12-0

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: (1S,2R)-2-甲氧基环己烷胺
• 中文别名: 5-硫杂氮醇胺,4-(1-甲基乙基)-
• 英文名称: cis-2-methoxycyclohexanamine
• 英文别名: (1S,2R)-2-Methoxycyclohexan-1-amine
• CAS: 141553-12-0
• 化学式: C₇H₁₅NO
• 分子量: 129.202
• InChiKey: NBWFBXBZOBXMHO-NKWVEPMBSA-N

物化性质

• 沸点：
  174.5±33.0 °C(Predicted)
• 密度：
  0.94±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (1S,2R)-2-甲氧基环己烷胺 在 三溴化硼 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 5.0h， 生成 (1S,2S)-N-[2-(pyrrolidin-1-yl)cyclohexyl]acetamide
  参考文献：
  名称：

  Novel, enantioselective synthesis of vicinal cyclohexane-diamines as key-intermediates for highly selective opioid kappa and sigma agonists.

  摘要：

  Enantiomers of Cyclohexane-1,2-diamines have been synthesized via two different synthetic approaches by asymmetric catalytic hydrogenation.

  DOI：

  10.1016/s0957-4166(00)80266-9
• 作为产物：
  描述：

  2-甲氧基环己酮 在 palladium on activated charcoal 、 镍 氢气 作用下， 以 乙醇 为溶剂， 生成 (1S,2R)-2-甲氧基环己烷胺
  参考文献：
  名称：

  Novel, enantioselective synthesis of vicinal cyclohexane-diamines as key-intermediates for highly selective opioid kappa and sigma agonists.

  摘要：

  Enantiomers of Cyclohexane-1,2-diamines have been synthesized via two different synthetic approaches by asymmetric catalytic hydrogenation.

  DOI：

  10.1016/s0957-4166(00)80266-9

文献信息

• The Rhodium Catalysed Direct Conversion of Phenols to Primary Cyclohexylamines
  作者：Patrick Tomkins、Carlot Valgaeren、Koen Adriaensen、Thomas Cuypers、Dirk E. De Vos

  DOI：10.1002/cctc.201800486

  日期：2018.9.7

  Cyclohexylamines are important intermediates in chemical industry, which are currently produced from petrochemical sources. Phenols, however, are an attractive sustainable feedstock. We here demonstrate the transformation of phenols with ammonia to primary cyclohexylamines. In contrast to previously reported chemistry which used palladium catalysts, we here show that rhodium is an excellent catalyst

  环己胺是化学工业中的重要中间体，目前是从石油化学来源生产的。但是，苯酚是一种有吸引力的可持续原料。我们在这里证明了苯酚与氨到伯环己胺的转化。与先前报道的使用钯催化剂的化学方法相反，我们在此表明​​铑是形成伯环己胺的极好催化剂。研究了不同的参数，结果表明该反应适用于提供高选择性的酚类化合物。
• SUBSTITUTED HETEROCYCLIC COMPOUNDS
  申请人：ZHUO Jincong

  公开号：US20100240671A1

  公开（公告）日：2010-09-23

  The present invention relates to substituted heterocyclic compounds of Formula I or XI: or pharmaceutically acceptable salts or N-oxides or quaternary ammonium salts thereof wherein constituent members are provided hereinwith, as well as their compositions and methods of use, which are histamine II4 receptor inhibitors useful in the treatment of histamine II4 receptor-associated conditions or diseases or disorders including, for example, inflammatory diseases or disorders, pruritus, and pain.

  本发明涉及式I或XI的取代杂环化合物： 或其药用可接受的盐或N-氧化物或季铵盐，其中所述成员在此提供，并且它们的组合物和使用方法，这些方法是组胺H24受体抑制剂，用于治疗组胺H24受体相关的疾病或疾病，包括例如炎症性疾病或疾病，瘙痒和疼痛。
• [EN] INDOLE CARBOXAMIDE DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS D'INDOLE CARBOXAMIDE ET LEURS UTILISATIONS
  申请人：NOVARTIS AG

  公开号：WO2014037900A1

  公开（公告）日：2014-03-13

  A compound of Formula (I) is provided that has been shown to be useful for treating a disease, disorder or syndrome that is mediated by the transportation of essential molecules in the mmpL3 pathway: (I) wherein R1, R2, R3, R4, R5 and R6 are as defined herein.

  提供了一种化合物，其化学式为（I），已被证明对治疗通过mmpL3途径中的必需分子的运输介导的疾病、紊乱或综合症具有益处：（I）其中R1、R2、R3、R4、R5和R6如本文所定义。
• SUBSTITUTED HETEROCYLIC COMPOUNDS
  申请人：Incyte Corporation

  公开号：US20130296327A1

  公开（公告）日：2013-11-07

  The present invention relates to substituted heterocyclic compounds of Formula I or XI: or pharmaceutically acceptable salts or N-oxides or quaternary ammonium salts thereof wherein constituent members are provided hereinwith, as well as their compositions and methods of use, which are histamine H4 receptor inhibitors useful in the treatment of histamine H4 receptor-associated conditions or diseases or disorders including, for example, inflammatory diseases or disorders, pruritus, and pain.

  本发明涉及式I或式XI的取代杂环化合物：或其药学上可接受的盐或N-氧化物或季铵盐，其中成员构成在此提供，以及它们的组合物和使用方法，它们是组胺H4受体抑制剂，用于治疗组胺H4受体相关的疾病或疾病或疾病，包括例如，炎症性疾病或疾病，瘙痒和疼痛。
• INDOLE CARBOXAMIDE DERIVATIVES AND USES THEREOF
  申请人：Jiricek Jan

  公开号：US20150175539A1

  公开（公告）日：2015-06-25

  A compound of Formula (I) is provided that has been shown to be useful for treating a disease, disorder or syndrome that is mediated by the transportation of essential molecules in the mmpL3 pathway: wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as defined herein.

  提供一种化合物，其化学式为（I），已被证明可用于治疗由mmpL3途径中必需分子的运输介导的疾病、障碍或综合症：其中R1、R2、R3、R4、R5和R6如此定义。